14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TENX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Tenax Therapeutics stock price down 2.82% on Thursday
(Updated on May 02, 2024)

Buy candidate since Apr 30, 2024 Loss -2.82% PDF

The Tenax Therapeutics stock price fell by -2.82% on the last day (Thursday, 2nd May 2024) from $3.90 to $3.79. During the last trading day the stock fluctuated 6.72% from a day low at $3.72 to a day high of $3.97. The price has fallen in 5 of the last 10 days but is still up by 2.99% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -21 thousand shares and in total, 17 thousand shares were bought and sold for approximately $64.57 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.56 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -19.97% during the next 3 months and, with a 90% probability hold a price between $2.05 and $9.19 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TENX Signals & Forecast

The Tenax Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $3.70 and $3.78. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, April 26, 2024, and so far it has risen 8.91%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Tenax Therapeutics stock

Tenax Therapeutics finds support from accumulated volume at $3.75 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.250 between high and low, or 6.72%. For the last week the stock has had daily average volatility of 6.69%.

Our recommended stop-loss: $3.64 (-3.98%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 4 days ago.)

Trading Expectations (TENX) For The Upcoming Trading Day Of Friday 3rd

For the upcoming trading day on Friday, 3rd we expect Tenax Therapeutics to open at $3.83, and during the day (based on 14 day Average True Range), to move between $3.49 and $4.09, which gives a possible trading interval of +/-$0.300 (+/-7.91%) up or down from last closing price. If Tenax Therapeutics takes out the full calculated possible swing range there will be an estimated 15.82% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.75 (1.06%) than the resistance at $3.99 (5.28%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Tenax Therapeutics stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 2.416 Buy Candidate Unchanged

Predicted Opening Price for Tenax Therapeutics of Friday, May 3, 2024

Fair opening price May 3, 2024 Current price
$3.83 ( 0.97%) $3.79

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TENX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.08 7.56 %
R2 3.98 5.04 %
R1 3.92 3.49 %
Current price: 3.79
Support S1 3.73 -1.55 %
S2 3.67 -3.11 %
S3 3.58 -5.63 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.59 21.11 %
R2 4.35 14.78 %
R1 3.99 5.28 %
Current price 3.79
Support S1 3.75 -1.06%
S2 3.71 -2.11%
S3 3.67 -3.17%

FAQ

What is the symbol for Tenax Therapeutics Stock and on which exchange is it traded?
The symbol for Tenax Therapeutics is TENX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Tenax Therapeutics Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

How to buy Tenax Therapeutics Stock?
Tenax Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Tenax Therapeutics Stock.

What's the current price of Tenax Therapeutics Stock?
As of the end of day on the May 02, 2024, the price of an Tenax Therapeutics (TENX) share was $3.79.

What is the 52-week high and low for Tenax Therapeutics Stock?
The 52-week high for Tenax Therapeutics Stock is $61.20 and the 52-week low is $3.47.

What is the market capitalization of Tenax Therapeutics Stock?
As of the May 02, 2024, the market capitalization of Tenax Therapeutics is 7.637M.

When is the next earnings date for Tenax Therapeutics?
The upcoming earnings date for Tenax Therapeutics is May 20, 2024.
Click to get the best stock tips daily for free!

About Tenax Therapeutics

Tenax Therapeutics Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertensi... TENX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT